Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
PaperCitations, authors & open-access status
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 170 citations, 2024 year and hybrid oa status.
170
Citations
2024
Year
hybrid
OA Status